|
|
Case Vignette: A 35-Year-Old Man with Difficulties at Work |
Feedback FAQ
| |
|
|
|

|
Reviewed by: David Baron, MSEd, DO
Test and sharpen your clinical skills by evaluating a patient having difficulties at work.
 Please review
this page completely before starting this course. Links to the course options
can be found at the bottom of this page. 
|
| Key Words: Evaluation, Treatment, Patient Case, ADHD, Primary Care |
Supported by an educational grant from:
Eli Lilly | |
|
 |
|
| OVERVIEW |
|
ADHD be masked as daily work stress due to unpleasant work conditions, unhealthy relationships, or innocuous absent-mindedness. How can you determine whether your adult patient’s complaints reflect common difficulties coping with life challenges or if you patient may have undiagnosed ADHD?
This course provides valuable tools, in a case-based approach, to help you create a patient-centered approach to treating a patient’s concerns. |
| | | [Top] | |
| OBJECTIVES |
|
| Upon completion of this course, you should be able to: |
| |
-
Recognize presenting symptoms and risk factors that may suggest ADHD
-
Conduct a thorough physical examination, with a focus on eliciting findings relevant to ADHD
-
Order appropriate laboratory and imaging tests to enable a differential diagnosis of ADHD
-
Perform a differential diagnosis for a patient with suspected ADHD
-
Plan treatment for an adult patient with ADHD
|
| | | [Top] | |
| TARGET AUDIENCE |
|
| This CME activity is designated for doctors of osteopathic medicine, primary care physicians, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with ADHD. | |
| | | [Top] | |
| FACULTY |
|
|
 |
| David Baron, MSEd, DO
[BioSketch]
|
| Professor & Chair,
Temple University School of Medicine, Department of Psychiatry,
Philadelphia, PA
|
| Disclosure: Speaker and consultant: Eli Lilly and Company; Advisor: Osmotica Pharmaceutical |
|
|
| | | [Top] | |
| CONFLICT OF INTEREST RESOLUTION |
|
MEBN's mission is to provide medical education that is accurate, fair-balanced, unbiased and evidence-based. MEBN strives to ensure that every educational activity maintains independence, objectivity and scientific rigor. All faculty participating in these activities are expected to disclose any (or no) relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of these relationship(s) will be listed prior to any educational activity.
All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation. Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.
Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose. |
| | | [Top] | |
| ACCREDITATION STATEMENT |
|
| Continuing Medical Education for Physicians |
 |
| Accreditation Statement |
| MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| |
| CME Credits |
| MEBN designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
| FDA Disclosure Statement |
| The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. |
| |
| Accreditation Period |
Original Release Date: September 2, 2008
Review Date: December 31, 2009
Expiration Date: December 31, 2011
|
| |
| Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net) | |
| | | [Top] | |
| DISCLAIMER |
|
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements. |
| | | [Top] | |
| Certificate Fees |
CME-TODAY offers FREE continuing medical education (CME) credits to recipients of the CD-ROM, program emails or CME-TODAY journal. Enter the CE Code listed on the CD-ROM, in the email or in the journal when prompted. This free offer expires on December 31, 2010. All others will be assessed a $4.00 processing fee. |
| | | [Top] | |
| HOW TO TAKE THIS COURSE |
|
Choose Your Format To Begin
Course: |
| |
-
Review
the course material
-
Complete the online post-test
-
Complete online program evaluation
-
Upon successful completion, a statement of credit will be
immediately available to print from a home or office printer.
-
Participation in the self-study activity should be completed in
approximately 15 minutes |
| |
| | | [Top] | |
|
|